中国医院用药评价与分析2017，Vol.17Issue(4)：537-539,542,4.DOI:10.14009/j.issn.1672-2124.2017.04.040
2013-2016年河南中医药大学第一附属医院门诊药房口服降糖药应用分析
Analysis on Application of Oral Hypoglycemic Drugs in Outpatient Pharmacy of the First Affiliated Hospital of Henan University During 2013-2016
樊鑫1
作者信息
- 1. 河南中医药大学第一附属医院药学部,河南 郑州 450000
- 折叠
摘要
Abstract
OBJECTIVE:To investigate the application status of oral hypoglycemic drugs in outpatient pharmacy of the First Affiliated Hospital of Henan University(hereinafter referred to as "our hospital") during 2013-2016.METHODS: Consumption sum ranking and defined daily dose system(DDDs) methods were adopted, statistical analysis was conducted on the application data of oral hypoglycemic drugs in terms of categories, consumption sum, DDDs and defined daily cost(DDC), ect.RESULTS: The consumption sum of different kinds of oral hypoglycemic drugs were stable during 2013-2016, among which the consumption sum of α-glucosidase inhibitor and sulfonylurea accounted almost 1/3.For four years, the medication frequence ranking of metformin took the lead.The medication frequence of gliclazide were in an increasing trend, the ranking of which dominated the second place and over acarbose in 2015.The consumption amount of glinides andnew antidiabetic drugs of DPP-4 were small, and TZDS drugs was the least.CONCLUSIONS: Metformin, gliclazide and acarbose play the leading role in outpatients of our hospital, and the selection of propensity in diabetics are larger, which is conform to Guide to Chinese Type 2 Diabetes(2013).Meanwhile, glinides and new antidiabetic drugs of DPP-4 are not widely applied.关键词
口服降糖药/销售金额/用药频度/限定日费用Key words
Oral hypoglycemic drugs/Consumption sum/DDDs/DDC分类
医药卫生引用本文复制引用
樊鑫..2013-2016年河南中医药大学第一附属医院门诊药房口服降糖药应用分析[J].中国医院用药评价与分析,2017,17(4):537-539,542,4.
